mercaptopurine

Generic: mercaptopurine

Labeler: florida pharmaceutical products, llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name mercaptopurine
Generic Name mercaptopurine
Labeler florida pharmaceutical products, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

mercaptopurine 50 mg/1

Manufacturer
Florida Pharmaceutical Products, LLC

Identifiers & Regulatory

Product NDC 71921-150
Product ID 71921-150_e7309808-5ae8-4a55-90e3-3992ace0da62
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA009053
Listing Expiration 2027-12-31
Marketing Start 2026-01-30

Pharmacologic Class

Classes
nucleic acid synthesis inhibitors [moa] nucleoside metabolic inhibitor [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71921150
Hyphenated Format 71921-150

Supplemental Identifiers

RxCUI
197931
UPC
0371921150250 0371921150021
UNII
E7WED276I5

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name mercaptopurine (source: ndc)
Generic Name mercaptopurine (source: ndc)
Application Number NDA009053 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 50 mg/1
source: ndc
Packaging
  • 25 TABLET in 1 BOTTLE (71921-150-02)
  • 250 TABLET in 1 BOTTLE (71921-150-25)
source: ndc

Packages (2)

71921-150-02 25 TABLET in 1 BOTTLE (71921-150-02) 71921-150-25 250 TABLET in 1 BOTTLE (71921-150-25)

Ingredients (1)

mercaptopurine (50 mg/1)

Linked Drug Pages (1)

Mercaptopurine ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "e7309808-5ae8-4a55-90e3-3992ace0da62", "openfda": {"upc": ["0371921150250", "0371921150021"], "unii": ["E7WED276I5"], "rxcui": ["197931"], "spl_set_id": ["e7309808-5ae8-4a55-90e3-3992ace0da62"], "manufacturer_name": ["Florida Pharmaceutical Products, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 TABLET in 1 BOTTLE (71921-150-02)", "package_ndc": "71921-150-02", "marketing_start_date": "20260130"}, {"sample": false, "description": "250 TABLET in 1 BOTTLE (71921-150-25)", "package_ndc": "71921-150-25", "marketing_start_date": "20260130"}], "brand_name": "Mercaptopurine", "product_id": "71921-150_e7309808-5ae8-4a55-90e3-3992ace0da62", "dosage_form": "TABLET", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "71921-150", "generic_name": "Mercaptopurine", "labeler_name": "Florida Pharmaceutical Products, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Mercaptopurine", "active_ingredients": [{"name": "MERCAPTOPURINE", "strength": "50 mg/1"}], "application_number": "NDA009053", "marketing_category": "NDA", "marketing_start_date": "20260130", "listing_expiration_date": "20271231"}